-N M Anstey Researcher Activity Profile

Research Author Detailed Information 

N M Anstey Publication Rate By Year

N M Anstey has published 9 paper(s) in 2007, 5 paper(s) in 2008, for a total of 14 research publications in total.

N M Nm Anstey Author Information

LAST NAME: anstey

FIRST NAME: N M

INITIALS: nm

AFFILIATION:

Papers

N M Anstey's Publication Record

1. Therapeutic response of multidrug-resistant Plasmodium falciparum and P. vivax to chloroquine and sulfadoxine-pyrimethamine in southern Papua, Indonesia. Year Published: 2007
International Health Program, Menzies School of Health Research and Charles Darwin University, Darwin, NT, Australia.
2. Improving case definitions for severe malaria. Year Published: 2007
International Health Division, Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Australia. anstey@menzies.edu.au
3. Clinical and pharmacological determinants of the therapeutic response to dihydroartemisinin-piperaquine for drug-resistant malaria. Year Published: 2007
Information Health Division, Menzies School of Health Research, Charles Darwin University, PO Box 41096, Casuarina, Darwin, NT 0811, Australia. ricprice@doctors.org.uk
4. Impaired nitric oxide bioavailability and L-arginine reversible endothelial dysfunction in adults with falciparum malaria. Year Published: 2007
International Health Division, Menzies School of Health Research and Charles Darwin University, Darwin NT 0810, Australia.
5. Chloroquine Resistant Plasmodium vivax: In Vitro Characterisation and Association with Molecular Polymorphisms. Year Published: 2007
International Health Program, Infectious Diseases Division, Menzies School of Health Research and Charles Darwin University, Darwin, Australia.
6. Impaired nitric oxide bioavailability and L-arginine reversible endothelial dysfunction in adults with falciparum malaria. Year Published: 2007
International Health Division, Menzies School of Health Research and Charles Darwin University, Darwin NT 0810, Australia.
7. Improving case definitions for severe malaria. Year Published: 2007
International Health Division, Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Australia. anstey@menzies.edu.au
8. Clinical and pharmacological determinants of the therapeutic response to dihydroartemisinin-piperaquine for drug-resistant malaria. Year Published: 2007
Information Health Division, Menzies School of Health Research, Charles Darwin University, PO Box 41096, Casuarina, Darwin, NT 0811, Australia. ricprice@doctors.org.uk
9. Vivax malaria: neglected and not benign. Year Published: 2007
International Health Program, Menzies School of Health Research and Charles Darwin University, Casuarina, Darwin, Northern Territory 0811, Australia. rnp@menzies.edu.au
10. Randomized, double-blind, placebo-controlled trial of granulocyte colony-stimulating factor in patients with septic shock. Year Published: 2008
Intensive Care, Royal Darwin Hospital, Darwin, Australia. dianne.stephens@nt.gov.au
11. Fatal community-associated methicillin-resistant Staphylococcus aureus pneumonia after influenza. Year Published: 2008
Infectious Diseases Division, Menzies School of Health Research, Darwin, NT, Australia. tongsyc@gmail.com.
12. Randomized, double-blind, placebo-controlled trial of granulocyte colony-stimulating factor in patients with septic shock. Year Published: 2008
Intensive Care, Royal Darwin Hospital, Darwin, Australia. dianne.stephens@nt.gov.au
13. Fatal community-associated methicillin-resistant Staphylococcus aureus pneumonia after influenza. Year Published: 2008
14. Determinants of in vitro drug susceptibility testing of Plasmodium vivax. Year Published: 2008
International Health Program, Infectious Diseases Division, Menzies School of Health Research and Charles Darwin University, Darwin, Australia.